Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

832
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
832
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.2K
Overview
83.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.

HLA·2026
Same author

Recommendations for HLA Genotyping Data Standards and Clinical Laboratory Staffing Considerations.

HLA·2026
Same author

Interaction between HLA-B leader peptide variants and cytomegalovirus serostatus is associated with early T cell-mediated rejection in kidney transplantation.

Frontiers in immunology·2026
Same author

Maternal-Foetal HLA-DQB1 Incompatibility Is Associated With Pregnancy-Induced Hypertensive Disorders in a Genetically Isolated Population.

HLA·2025
Same author

Swine Xenografts Share Few Predicted Indirectly Recognisable SLA-Derived Epitopes With HLA-Derived Epitopes From Human Kidney Grafts.

HLA·2025
Same author

Peptide Sharing Between CMV and Mismatched HLA Class I Peptides Promotes Early T-Cell-Mediated Rejection After Kidney Transplantation.

HLA·2024

Related Experiment Video

Updated: Jan 3, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K

PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation.

Kirsten Geneugelijk1, Eric Spierings2

  • 1Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. c.c.a.geneugelijk-2@umcutrecht.nl.

Immunogenetics
|November 20, 2019
PubMed
Summary

Human leukocyte antigen (HLA) mismatches increase transplant rejection risk. The PIRCHE-II algorithm helps predict and minimize this risk, aiming for better patient outcomes and improved graft survival in solid organ transplantation.

Keywords:
EpitopesHLAHistocompatibilityMatchingPIRCHE-IISolid organ transplantationTransplantation

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.5K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.2K

Related Experiment Videos

Last Updated: Jan 3, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.5K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.5K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.2K

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • Computational biology

Background:

  • Human leukocyte antigen (HLA) mismatches are a primary cause of alloreactivity and graft rejection in solid organ transplantation.
  • The identification of numerous new HLA alleles has increased the complexity of HLA matching, making risk assessment challenging.
  • Current methods struggle to accurately predict the likelihood of alloreactive responses to HLA mismatches.

Purpose of the Study:

  • To review the utility of algorithms in estimating alloreactive risk after solid organ transplantation.
  • To highlight the PIRCHE-II algorithm as a tool to minimize alloreactivity towards HLA mismatches.
  • To discuss the potential of computational approaches for improving graft survival.

Main Methods:

  • Review of current literature on HLA matching and alloreactivity prediction.
  • Focus on the PIRCHE-II (Predicted Indirectly ReCognizable HLA Epitopes) algorithm.
  • Discussion of simulation approaches for risk assessment.

Main Results:

  • The PIRCHE-II algorithm demonstrates promise in minimizing alloreactivity by predicting indirectly recognizable HLA epitopes.
  • Integration of PIRCHE-II with other algorithms and simulations offers a more refined estimation of individual alloreactive risk.
  • These computational tools aim to improve the accuracy of HLA mismatch assessment.

Conclusions:

  • Algorithms like PIRCHE-II represent a significant advancement in managing HLA mismatches in transplantation.
  • Improved risk estimation through algorithms can lead to more personalized immunosuppression strategies.
  • The ultimate goal is to enhance long-term graft survival and patient outcomes in solid organ transplantation.